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greliable method for the assessment of the
mitral valve (MV) area is essential for the
management of patients with a prosthetic
MV. In this study, we assess the feasibil-
ity of 3-dimensional (3D) echocardiography to
directly measure the mechanical MV orifice area in
both an in vitro study of prosthetic valve function
under controlled-flow conditions as well as in a
clinical imaging protocol. The 3D anatomic dia-
stolic area (ADA) and 3D color Doppler diastolic
area were compared with a manufacturer-defined
geometric orifice area (GOA) and Doppler-derived
effective orifice area (EOA) for normal mechanical
MVs (Fig. 1).
M E T H O D S
In vitro study. A pulsatile circulatory loop was de-
veloped in our laboratory and previously described
in detail (1,2). In brief, the setup consists of an
inflow conduit leading to a flow chamber represent-
ing the left atrium, a valve orifice containing a
mechanical mitral prosthesis, a receiving chamber
simulating the left ventricle, and an outflow con-
duit, along with ultrasound imaging windows. The
modular imaging chamber permits assessment of
multiple valve sizes under tailored hemodynamic
flow conditions. For each St. Jude Medical mechan-
ical MV (St. Jude Medical, St. Paul, Minnesota)
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2011, accepted June 9, 2011.ize tested (23, 25, and 31 mm), we assessed 3
ifferent pulsatile inflow volumes (range 51 to 97
l/beat) at a rate of 72 beats/min. A 3.5-MHz (S3)
oppler transducer (iE33, Philips Medical Sys-
ems, Andover, Massachusetts) was used to assess
ransorifice flow. The Doppler-derived EOA was
alculated as stroke volume divided by the time-
elocity integral through the mitral prosthesis. 3D
ive and 3D full-volume color Doppler (7-beat
titch) images were acquired (X3 transducer, Philips
edical Systems) and then analyzed offline using a
LAB workstation (version 6, Philips Medical
ystems). An average of 3 measurements was re-
orded for each imaging modality. All off-line
easurements were performed by 2 observers
linded to valve size and the manufacturer-defined
OA.
linical study. Patients scheduled to undergo clini-
ally indicated transesophageal echocardiography
TEE) or prosthetic MV implantation (intraopera-
ive TEE) were approached for study participation.
atients with prosthesis malfunction or coexisting
ortic regurgitation of more than mild severity were
xcluded. Thirty-five consecutive patients with a
rosthetic MV were approached for the study. Ten
atients were excluded due to moderate to severe
aravalvular regurgitation (n  2), partial leaflet
bstruction (n  1), bioprosthetic mitral valve (n 
), and insufficient 3D TEE image quality (n  4).
rosthetic valve type and size were obtained from
he patient’s valve information card, the operative
eport, or the valve manufacturer’s implant data-
ase. The research protocol was approved by the
nstitutional review board, and all participants pro-
ided written consent.
-dimensional and 3D transesophageal echocardio-
raphic image acquisition. TEE was performed us-
ng an X7-2t transducer (iE33, Philips Medical
s
t
d
l
p
p
“
i
s
p
t
i
w
o
b
m
w
i
a
t
V
w
f
w
r
b
p
i
t
a
a
r
t
b
a
d
m
y
s
w
r
t
t
w
d
m
t
r
ardiography
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 5 , 2 0 1 2
M A Y 2 0 1 2 : 4 7 8 – 8 3
Krim et al.
3D Echo Assessment of Prosthetic Mitral Valve Area
479Systems). Peak and mean mitral gradients were
measured from continuous wave mitral inflow
Doppler. Live 3D (zoom mode), 3D full-volume
(4-beat stitch), and 3D color Doppler (7-beat
stitch) image data were acquired from the mid-
esophageal view. Gain settings were optimized to
minimize dropout of visible prosthetic leaflet and
annular surfaces. Color Doppler velocity baseline
and write priority settings were not adjusted. Data
were transferred to an off-line analysis system
(QLAB version 6, Philips Medical Systems) and
stored. 3D image data were subsequently analyzed
by 2 independent observers blinded to the
2-dimensional (2D) Doppler data, prosthetic valve
size, and the manufacturer-defined GOA.
3D data analysis. The mitral orifice area was mea-
ured from 3 consecutive mid-diastolic frames and
hen averaged. The following protocol was used to
efine the diastolic valve area. First, 2 orthogonal
ong-axis imaging planes were defined through the
rosthetic valve. Then the short axis of the open
rosthetic valve was identified by adjustment of the
slider” data cropping feature within the short-axis
mage tile (Fig. 2) (Online Video 1). A true
hort-axis slice through the mid portion of the
rosthesis was confirmed by any-plane rotation of
he volume-rendered image tile (Fig. 2D). The
nner circumference of the visible short-axis area
as then manually traced at the mid-level of the
pen prosthesis. As shown in Figure 2C, the
ileaflet disk area was not excluded from the area
easured. In addition, the internal valve diameter
as measured from the short-axis view. The same
mage cropping and measurement methods were
lso applied to 3D color Doppler datasets used for
he in vitro and clinical imaging studies (Online
ideo 2).
2D echocardiography. 2D and Doppler transtho-
racic echocardiography was performed within 24 h
of TEE using a 3.5-MHz probe and a commercially
available ultrasound system (iE33, Philips Medical
Systems). The stroke volume was derived as the
product of the cross-sectional area of the left ven-
tricular outflow and time-velocity integral of flow.
Mitral inflow velocity through the prosthetic valve
was recorded with continuous wave Doppler from
the apical window. The Doppler-derived EOA was
calculated using the continuity equation (EOA 
stroke volume/time-velocity integral) through the
mitral prosthesis by continuous wave Doppler (3).
Reproducibility analysis. Intraobserver variability
as assessed using repeated measurements per-
ormed by the same observer 3 months later,hereas interobserver variability was evaluated in a
andom selection of 15 patients by repeated analysis
y a second observer, blinded to the results of all
revious measurements. The percentage of variabil-
ty was defined from the absolute difference be-
ween repeated measurements divided by the aver-
ge of the 2 measurements.
Statistical analysis. Hemodynamic characteristics
nd summary echocardiographic data were summa-
ized as mean  SD (range). The Pearson correla-
ion coefficient was used to assess the relationship
etween the mean 3D ADA, 3D color Doppler
rea, Doppler-derived EOA, and manufacturer-
efined GOA. Pairwise multiple-comparison
ethod (Holm-Sidak) was used to assess for anal-
sis of variance. A p value 0.05 was considered
tatistically significant.
R E S U L T S
The 3D anatomic diastolic valve area was
not different by live 3D zoom or 3D
full-volume (stitched) imaging methods
(p  NS) in the in vitro or clinical study.
Acquisition of 3D TEE images added
approximately 2 min to the standard TEE
protocol per patient; the time required for
complete analysis of each 3D dataset by an
experienced observer was approximately 4
min.
In vitro study. A comparison of the dia-
stolic valve area for each valve size studied
in vitro is presented in Figure 3. The mean
3D ADA, 3D color Doppler area, and Doppler
EOA for the 23-mm valve (GOA 2.6 cm2) were 2.4
cm2, 1.8 cm2, and 1.6 cm2, respectively; for the
25-mm valve (GOA 3.1 cm2), the measured areas
ere 3.0 cm2, 2.6 cm2, and 2.0 cm2, respectively,
and for the 31-mm valve (GOA 5.18 cm2), the
measured areas were 4.0 cm2, 3.2 cm2, and 2.6 cm2,
espectively. For each valve size, the 3D ADA was
he largest, whereas EOA by the continuity equa-
ion was the smallest. The 3D color Doppler area
as of an intermediate value. Changes in flow rates
id not affect either anatomic or color Doppler area
easurements by 3D echocardiography (correla-
ions: r  0.55, p  NS and r  0.66, p  NS,
espectively).
Clinical study. The clinical characteristics and base-
line echocardiographic measures of the 25 patients
with normal mechanical MV function are shown in
Table 1. Atrial fibrillation was present in 4 patients.
A B B
A N D
2D
3D
ADA
EOA
GOA
MV
TEE
echocMechanical valve sizes ranged from 23 to 31R E V I A T I O N S
A C R O N YM S
2-dimensional
3-dimensional
anatomic diastolic area
effective orifice area
geometric orifice area
mitral valve
transesophagealmm.
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480All patients demonstrated normal transprosthetic
gradients (mean 4.5  2 mm Hg; range 2 to 10
mm Hg). Mild paravalvular regurgitation was noted
in 5 patients.
The prosthetic MV was adequately visualized,
and 3D image quality was diagnostic with live 3D
and 3D color Doppler images obtained in all
patients. The mean GOA was 3.9  0.8 cm2 and
the mean 3D ADA was 3.1  0.7 cm2. The 3D
color Doppler diastolic area was smaller at 2.5 
0.6 cm2, whereas Doppler-derived EOA was the
smallest and averaged 2.1  0.6 cm2. The
oppler-derived EOA could not be calculated
Figure 1. Planimetry Tracing of Diastolic Areas
Manual tracing of the inner prosthetic valve circumference of 29 m
(3D) live anatomic diastolic area and color Doppler diastolic area. T
frames for all 3D modalities.
Measurement of 3D Anatomic Diastolic Area
gonal long-axis imaging planes were deﬁned (A,B) through the
valve, and the true short axis through the mid-portion of the
thetic valve was identiﬁed (C), and conﬁrmed by any-plane rota-or 3 patients due to inadequate left ventricular
utflow tract images or poor pulsed-wave Dopp-
er quality.
The mean 3D ADA was smaller, but correlated
ell with the GOA (3.1  0.7 cm2 vs. 3.9  0.8
m2; r  0.83, p  0.001) (Fig. 4A). The 3D color
Doppler area showed modest correlation with the
GOA (2.5  0.6 cm2; r  0.69, p  0.001) (Fig.
4B). For all patients, the Doppler-derived EOA
was the smallest area measure and demonstrated a
weak but statistically significant correlation with the
GOA (2.1 0.6 cm2; r 0.51, p 0.044) (Fig. 4C).
There was a strong correlation between the 3D
measured valve internal diameter and the manufac-
turer valve internal diameter (r  0.89, p  0.001).
Reproducibility. For repeated measures of 3D ana-
tomic diastolic area, the interobserver and intraob-
server variability was 8  7% and 5  3%, respec-
tively. For repeated measures of the 3D color
Doppler diastolic area, the interobserver and intra-
observer variability was 8  4% and 7  3%,
respectively.
D I S C U S S I O N
The evaluation of prosthetic heart valve function
has long been a clinical challenge. This report is the
first to describe the use of matrix 3D TEE to
provide a single direct measurement of the ana-
tomic area or EOA of St. Jude Medical valves under
normal flow conditions. Our results demonstrate 3
key findings. First, direct measurement of the ana-
tomic area by 3D TEE is feasible and reproducible.
Second, the anatomic area by 3D TEE correlates
well with the manufacturer’s GOA but with con-
t. Jude mechanical valve was used to deﬁne the 3-dimensional
itral inﬂow area was recorded from 3 consecutive mid-diastolicm S
he mFigure 2.
Two ortho
prosthetic
open pros
tion of the volume-rendered tile (D). See Online Video 1.sistent underestimation bias. Third, the 3D color
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481Doppler area is a relatively simple and reproducible
measure of the effective diastolic flow area.
Direct valve area assessment. Only 1 previous study
described a possible role for 3D TEE in the
quantitative examination of the prosthetic valve area
(4), and there are no published reports of the
relationship between the 3D color Doppler diastolic
area and the GOA or Doppler-derived EOA. We
performed 3D color Doppler assessment of the
valve area and were able to provide the first com-
parison of a directly measured 3D effective diastolic
flow area and a direct measurement of the 3D
ADA.
The GOA is derived from the internal valve
diameter of the prosthesis and is measured in vitro
by the valve manufacturer. In both our in vitro and
clinical imaging studies, we observed that the 3D
ADA is smaller than the reported GOA for all
valves (Figs. 3 and 4). This discrepancy is likely due
to limitations in the spatial resolution of the 3D
imaging methods.
Compared with 3D ADA, the color Doppler–
derived area was consistently smaller. In the
clinical study, there was no significant difference
between the average 3D color Doppler diastolic
area and the Doppler-derived EOA. It is well
recognized that the EOA is often smaller than
the GOA for both native and prosthetic valve
flow (5,6). This study is the first to investigate the
relationship between a direct measurement of the
EOA by 3D color Doppler and other measures of
valve function. The data presented (Fig. 4B)
show a significant correlation between the 3D
color Doppler– derived area and the GOA but an
increasing discrepancy as valve size increases. It
was previously reported that there is less discrep-
ancy between the EOA and GOA with smaller
prosthetic valves, with the explanation that
smaller valves use the potential flow area more
completely than do large valves (7). Overall, our
in vitro and clinical data support the concept that
a measure of the short-axis color Doppler area
represents an effective area rather than a geomet-
ric flow area.
Doppler-derived EOA. The Doppler-derived EOA is
a measure of the physiological area occupied by
blood flow and not the true anatomic area of the
prosthesis. As such, the EOA, not GOA, deter-
mines the mitral diastolic gradient. Although the
EOA is a more reliable index of prosthetic MV
function than measurement of the mean gradient
alone, it is important to note that the higher
velocity across the smaller central orifice (relativeto the larger outside orifices) of bileaflet pros-
thetic valves results in underestimation of the
continuity equation– derived EOA (3,7). Fur-
thermore, the Doppler-measured EOA of the
prosthetic MV is a composite of several measure-
ments and geometric assumptions that may each
be prone to error.
The simplicity of the directly measured 3D area
assessment is reflected in the observer variability.
We report 8% interobserver variability and 5%
intraobserver variability, which compares favorably
with the respective 15% and 9% repeated-measures
variability reported for the Doppler-derived EOA
of mechanical MVs (7).
Clinical implications. We examined the St. Jude
edical prosthesis because it is the most com-
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Figure 3. Valve Area Measurements by Different Methods in th
In Vitro Study
Three valves of different sizes studied under different ﬂow conditio
each valve, the 3-dimensional (3D) anatomic diastolic area was the
whereas the effective oriﬁce area (EOA) by the continuity equation
smallest; 3D color Doppler was intermediate.
Table 1. Patient Characteristics and Echocardiographic Data
Mean  SD Range
Age, yrs 62 17 21–86
Female, n (%) 14 (56) —
Heart rate, beats/min 72 13 54–100
BSA, m2 1.9 0.3 1.4–2.5
Ejection fraction, % 55 14 27–71
SVLVOT, ml 68 17 44–108
Mean gradient, mm Hg 4.5 2.4 2–10
TVImitral, cm 33 7 23–46
EOA by continuity equation, cm2 2.1 0.6 1.2–3.2
EOA, indexed to BSA, cm2/m2 1.1 0.3 0.7–1.8
BSA body surface area; EOA effective oriﬁce area; LVOT left ventriculare
ns. For
largest,
was theoutﬂow tract; SV  stroke volume; TVI  time-velocity integral.
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482monly implanted prosthetic valve worldwide (3)
and because its hydrodynamic flow profile is
complex. We anticipate that the area measure-
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Figure 4. Area Measurements Compared With Manufacturer’s O
Relationship between manufacturer geometric oriﬁce area and the
continuity equation (C). Abbreviations as in Figure 3.
Abnormal Mechanical Valve Function
phageal echocardiography depicts a 27-mm St. Jude Medical valve
rer’s geometric oriﬁce area, 3.7 cm2) with partial leaﬂet obstruction. The
aﬂet does not open (A); see Online Video 2. 3D color Doppler demon-
metrical diastolic ﬂow through only the left side of the prosthesis (B).
ic diastolic area measured at the midpoint of the prosthesis appears nor-
color Doppler diastolic area appears markedly reduced (D), consistent
duced Doppler EOA (0.7 cm2) and increased Doppler mean gradient
). See Online Video 3. Abbreviation as in Figure 3.ment techniques that we describe are likely to be
applicable to other types of prosthetic valves. In this
initial study, we did not enroll patients with valve
dysfunction to assess the performance of 3D area
measures in this important population. One area for
application of these novel measures is in the identifi-
cation of patients with prosthesis-patient mismatch. A
direct 3D measurement of the anatomic and color
Doppler valve area in these patients would be helpful,
particularly when the valve size is not known. Another
application of this method is for suspected prosthetic
valve obstruction, as shown in Figure 5. In this clinical
example, 3D TEE demonstrated leaflet obstruction.
3D color Doppler confirmed no diastolic flow through
the medial half of the valve and a reduced color
Doppler area, highlighting the potential value of 3D
echocardiography (Online Video 3). Because our clin-
ical study included only patients with normal MVs, it
is important to validate our findings in a cohort of
patients with abnormal prosthetic valve function and
other types of prostheses.
C O N C L U S I O N S
Direct measurement of the mechanical MV ori-
fice area by 3D echocardiography is feasible and
simple and correlates well with manufacturer-
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483rapidly assess prosthetic valve function and to
provide a direct measurement of the EOA, and
may therefore be an important adjunct to thetion of prosthetic valves with echocardi-
4
5
6
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For supplementary videos and their legends,
please see the online version of this article.
